KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GSK) Equity Average (2016 - 2023)

Historic Equity Average for Gsk (GSK) over the last 11 years, with Q4 2023 value amounting to $16.6 billion.

  • Gsk's Equity Average changed N/A to $16.6 billion in Q4 2023 from the same period last year, while for Dec 2023 it was $16.6 billion, marking a year-over-year change of. This contributed to the annual value of $16.7 billion for FY2024, which is 1215.22% up from last year.
  • As of Q4 2023, Gsk's Equity Average stood at $16.6 billion.
  • In the past 5 years, Gsk's Equity Average registered a high of $16.6 billion during Q4 2023, and its lowest value of $3.2 billion during Q3 2019.
  • Moreover, its 3-year median value for Equity Average was $6.6 billion (2019), whereas its average is $8.1 billion.
  • Over the last 5 years, Gsk's Equity Average had its largest YoY gain of 14667.0% in 2019, and its largest YoY loss of 674.88% in 2019.
  • Gsk's Equity Average (Quarter) stood at $8.2 billion in 2019, then rose by 29.38% to $10.6 billion in 2021, then soared by 57.22% to $16.6 billion in 2023.
  • Its Equity Average was $16.6 billion in Q4 2023, compared to $10.6 billion in Q1 2021 and $8.2 billion in Q4 2019.